Turn Therapeutics (TTRX) Operating Leases (2024 - 2026)

Turn Therapeutics' Operating Leases history runs 3 years deep, the most recent figure standing at $21539.0 for Q1 2026.

• In Q1 2026, Operating Leases changed N/A year-over-year to $21539.0; the TTM figure through Mar 2026 stood at $21539.0 (changed N/A YoY), while the FY2025 annual figure was $34081.0, down 57.6% from the prior year.
• Operating Leases for Q1 2026 stood at $21539.0, down from $34081.0 in the prior quarter.
• The five-year high for Operating Leases was $80376.0 in Q4 2024, with the low at $21539.0 in Q1 2026.
• The 3-year median for Operating Leases is $40212.5 (2025), against an average of $45585.0.
• Peak annual rise in Operating Leases reached 57.6% in 2025, while the deepest fall reached 57.6% in 2025.
• Turn Therapeutics' Operating Leases stood at $80376.0 in 2024, then slumped by 57.6% to $34081.0 in 2025, then sank by 36.8% to $21539.0 in 2026.
• Business Quant data shows TTRX's Operating Leases at $21539.0 in Q1 2026, $34081.0 in Q4 2025, and $46344.0 in Q3 2025.